VICO Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating t...
Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment f...
In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bact...
Fujitsu Japan has announced that it will initiate a new research project with a research team led by Japan's Resear...
UK-based Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has signed an agreement with the m...
Sosei Group Corporation has been notified by Pfizer that the first subject in a clinical trial has been dosed with a new...
Shineco, Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, has annou...
South Korea's Pharmcadd Co. Ltd., a developer of artificial intelligence (AI) and physics-based drug discovery platform,...
RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and va...
Pureos Bioventures announces the final closing of its first fund BB Pureos Bioventures LP (Pureos) with a committed...
The inherent heterogeneity of diseases such as cancer is driving the field of personalized (precision) therapies. Within...
Hitachi, Ltd. and Axcelead, Inc. have announced that they have agreed on a comprehensive collaborative partnership to de...
Shanghai Genechem Co., Ltd., a discovery company dedicated to novel drug target discovery and development of novel thera...
Four months after raising its seed round from Hoxton Ventures and dRX Capital, a venture arm of Novartis Pharma AG, ...
A global leading biotech company GenScript Biotech Corporation has announced that the Company has entered into a strateg...
PerkinElmer, Inc., has announced that its Signals ™ computing platform for documentation, workflow ...
Fujitsu has announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japa...
German firm Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Japan based Eisai have announced that b...
